ÂÜÀòÂÒÂ×

The Leadership Team at n-Lorem Foundation is responsible for guiding the organization’s strategic direction and ensuring the successful development and delivery of experimental antisense oligonucleotide (ASO) medicines for patients with ultra-rare diseases. This team collaborates to drive innovation, oversee operational efficiency, and foster partnerships, all while championing the foundation’s mission to make impactful treatments accessible to those who need them.